SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology

July 11, 2017 08:36 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The... Read more

Promega Intends to Seek FDA Approval for Microsatellite Instability Assay to Assist in Strategic Cancer Decisions

MADISON, WI USA (July 6, 2017) Promega Corporation intends to seek US Food and Drug Administration approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. MSI status is a measure of mismatch-repair deficiency commonly found in solid tumors. In addition to the colorectal... Read more

Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections

Basel, 03 July 2017 Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections With more than 150,000 affected patients per year, MRSA and SA are major sources of healthcare and community associated infections in Europe Fast detection reduces the risk of transmission within the hospital, but classical... Read more

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more

Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project. In a little over a year since Illumina announced the Bioinformatics and Clinical Interpretation Partnership with Genomics England, the partnership has now set... Read more

DiaSorin and Tecan to collaborate in new platform development

Saluggia, Italy and Männedorf, Switzerland, June 23, 2017 – DiaSorin (FTSE Italy Mid Cap: DIA) and Tecan Group (SIX Swiss Exchange: TECN) announced today that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its Nucleic Acid extraction platform. The new platform will... Read more

PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects

MENLO PARK, Calif., June 22, 2017 (GLOBE NEWSWIRE) — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring Harbor Laboratory, the USDA’s Agricultural Research... Read more

PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects

MENLO PARK, Calif., June 22, 2017 (GLOBE NEWSWIRE) — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring Harbor Laboratory, the USDA’s Agricultural Research... Read more